搜索临床试验以:OX40 ligand (OX40)
总计593个结果
-
Nantes University HospitalChugai Pharmaceutical; French Innovative Leukemia Organisation完全的
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)完全的
-
Institut de Cancérologie de Lorraine完全的
-
Southwest Hospital, China未知
-
Astellas Pharma Global Development, Inc.Yale University完全的
-
Children's Hospital Los Angeles完全的肉芽肿 | 贫血 | 血小板减少症 | 中性粒细胞减少症 | 镰状细胞性贫血症 | 地中海贫血 | 尼曼匹克病 | Wiskott-Aldrich 综合症 | 骨质疏松症 | 岩藻糖苷沉着症 | 切迪亚克东综合症 | 赫勒病美国
-
Ligand PharmaceuticalsMedpace, Inc.完全的
-
Weill Medical College of Cornell University撤销
-
Weill Medical College of Cornell UniversityNational Cancer Institute (NCI)撤销
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...终止
-
Janssen Research & Development, LLC完全的
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense完全的
-
Duke University终止
-
Alaunos Therapeutics完全的
-
Ligand PharmaceuticalsMedpace, Inc.; Beckloff Associates, Inc.完全的
-
University of Southern CaliforniaNational Cancer Institute (NCI)终止
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy, Baylor College...完全的
-
Centocor Research & Development, Inc.完全的
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI); Southwest Oncology Group; Cancer and Leukemia Group B完全的
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)完全的
-
University Hospital, Clermont-Ferrand完全的
-
M.D. Anderson Cancer Center完全的
-
Ligand Pharmaceuticals完全的
-
Centre for Addiction and Mental HealthPfizer完全的
-
Northwestern University完全的